Nyrada Inc – 2025 EGM Letter to Shareholders, Notice of Meeting and Proxy

Nyrada Inc (ASX:NYR) (“Nyrada” or “Company”), a drug discovery and development company focused on innovative Transient Receptor Potential Canonical (TRPC) ion channel blockers, attaches the following documents in relation to its 2025 General Meeting (“EGM”):
• EGM Letter to Shareholders;
• EGM Notice of Meeting; and
• Proxy Form.